Concepedia

Tamás Masszi

TM

Statistics

Publications

134

Citations

15.9K

H-Index

53

Active since

1991

Affiliations

Unified Szent István and Szent László Hospital(Current)

Semmelweis University

Charles University

The University of Texas MD Anderson Cancer Center

Hôpital Saint-Louis

Tamás Masszi is an author at Unified Szent István and Szent László Hospital specializing in medicine, hematologic malignancy therapy, and pharmacology.

ORCID

Publications per year

1991–2023

134

Publications

134

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

Antonio Palumbo, Asher Chanan‐Khan, Katja Weisel et al. · New England Journal of Medicine · 2016 · 1.5K citations · Full text

, , +17

Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

A. Keith Stewart, S. Vincent Rajkumar, Meletios Α. Dimopoulos et al. · New England Journal of Medicine · 2014 · 1.3K citations · Full text

, , +16

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Philippe Moreau, Tamás Masszi, Norbert Grząśko et al. · New England Journal of Medicine · 2016 · 1.1K citations · Full text

, , +14

Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Martin Grießhammer et al. · New England Journal of Medicine · 2015 · 872 citations

, , +14

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

Meletios Α. Dimopoulos, Philippe Moreau, Antonio Palumbo et al. · The Lancet Oncology · 2015 · 849 citations · Full text

, , +17

1–5 of 134